Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Postoperative Pain in Laparoscopic Uterine Surgery
NCT06300944Completed
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Dec 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in postoperative pain (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Incidence of moderate to severe pain at 24 hours, Incidence of adverse reactions at 48 hours and 1 more. Started Dec 2023; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06300944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06300944.